Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Июнь 24, 2023
Abstract
Comprehensive
immunological
profiles
have
not
been
studied
in
relation
to
methamphetamine
(MA)
use,
MA
dependency,
or
MA-induced
psychosis
(MAP).
Using
the
BioPlex
Pro
Human
Cytokine
48-Plex
panel,
this
study
measured
M1
macrophage,
T
helper
(Th)-1,
Th-2,
growth
factor,
and
chemokine
profiles,
as
well
immune
inflammatory
response
system
(IRS)
compensatory
immunoregulatory
(CIRS)
peripheral
blood
samples
from
patients
with
use
(n=51),
dependence
(n=47),
MAP
(n=43)
comparison
healthy
controls
(n=43).
We
discovered
that
persistent
had
a
robust
dose-dependent
suppressive
impact
on
all
suggesting
extensive
immunosuppression.
The
most
reliable
biomarker
profile
of
is
combination
substantial
CIRS
suppression
rise
selected
pro-inflammatory
cytokines,
namely
CCL27
(CTACK),
CCL11
(eotaxin),
interleukin
(IL)-1α.
In
addition,
dependency
related
more
severe
immunosuppression,
demonstrated
by
lower
stem
cell
factor
higher
IL-10
levels.
significant
decrease
particularly
CIRS,
an
increase
CCL5
(RANTES),
IL-1α,
IL-12p70
signaling.
conclusion,
long-term
severely
undermine
homeostasis.
This
results
widespread
which
may
likelihood
infectious
illness
exacerbate
disorders
such
hepatitis
AIDS.
Elevated
levels
CCL5,
CCL11,
CCL27,
and/or
be
associated
(atherosclerosis,
cutaneous
inflammation,
aberrations,
hypospermatogenesis)
central
(neuroinflammation,
neurotoxic,
neurodegenerative,
depression,
anxiety
psychosis)
side
effects.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 3, 2024
Abstract
Background
Chronic
methamphetamine
(MA)
usage
is
linked
to
oxidative
stress
(OS),
AGE-RAGE
stress,
changes
in
magnesium,
calcium,
and
copper,
increased
psychotic
symptoms
neurocognitive
deficits.
Nevertheless,
it
still
unclear
whether
the
latter
impairments
are
mediated
by
these
biological
pathways.
Aims
The
purpose
of
this
study
was
investigate
relationships
between
neurocognition,
aforementioned
biomarkers,
symptoms.
Methods
We
recruited
67
participants,
namely
40
patients
diagnosed
with
MA-substance
use
27
healthy
controls,
assessed
Brief
Assessment
Cognition
Schizophrenia
(BACS),
psychosis,
excitation,
formal
thought
disorders,
OS
toxicity
(computed
as
sum
myeloperoxidase
(MPO),
oxidized
high-density
lipoprotein
(HDL),
low-DL,
malondialdehyde),
antioxidant
defenses
(catalase,
glutathione
peroxidase,
total
capacity,
zinc,
HDL),
advanced
glycation
end
products
(AGEs),
soluble
AGE
receptors.
Results
were
able
extract
one
validated
latent
vector
from
Mini
Mental
State
Examination
score
BACS
tests
results
(including
executive
functions,
verbal
fluency,
attention),
labeled
general
cognitive
decline
(G-CoDe).
found
that
76.1%
variance
G-CoDe
explained
toxicity,
lowered
defenses,
number
episodes,
MA
dose.
In
use,
MPO
significantly
associated
G-CoDe.
Conclusions
induces
mild
through
MA-induced
activation
detrimental
outcome
pathways,
including
suppression
protective
pathways
(antioxidants).
Increased
OS,
MPO,
new
drug
targets
prevent
deficits
psychosis
due
use.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 19, 2024
Abstract
Background
Using
machine
learning
methods
based
on
neurocognitive
deficits
and
neuroimmune
biomarkers,
two
distinct
classes
were
discovered
within
schizophrenia
patient
samples.
The
first,
major
psychosis
(MNP)
was
characterized
by
cognitive
in
executive
functions
memory,
higher
prevalence
of
psychomotor
retardation,
formal
thought
disorders,
mannerisms,
psychosis,
hostility,
excitation,
negative
symptoms,
diverse
aberrations.
Simple
(SNP)
the
less
severe
phenotype.
Aims
study
comprised
a
sample
40
healthy
controls
90
individuals
diagnosed
with
schizophrenia,
divided
into
MNP
SNP
previously
determined
criteria.
Soft
Independent
Modelling
Class
Analogy
(SIMCA)
performed
using
test
results
measurements
serum
M1
macrophage
cytokines,
IL-17,
IL-21,
IL-22,
IL-23
as
discriminatory/modelling
variables.
model-to-model
distances
between
MNP+SNP
computed,
top
discriminatory
variables
established.
Results
A
notable
SIMCA
distance
146.1682
observed
control
group;
top-3
lowered
motor
speed,
an
activated
T
helper-17
axis,
working
memory.
This
successfully
differentiated
from
yielding
19.3.
activation,
verbal
fluency,
prominent
features
versus
SNP.
Discussion
Based
assessments
immune-linked
neurotoxic
IL-6/IL-23/Th-17
we
found
that
are
qualitatively
classes.
Future
biomarker
research
should
always
examine
biomarkers
phenotypes,
rather
than
combined
+
or
group.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Май 6, 2024
Abstract
Background
The
pathophysiology
of
amnestic
Mild
Cognitive
Impairment
(aMCI)
is
largely
unknown,
although
some
papers
found
signs
immune
activation.
Aims
To
assess
the
cytokine
network
in
aMCI
after
excluding
patients
with
major
depression
(MDD)
and
to
examine
profiles
quantitative
(qMCI)
distress
symptoms
old
age
(DSOA)
scores.
Methods
A
cross-sectional
study
was
conducted
on
61
Thai
participants
60
healthy
adults
(both
without
MDD).
Bio-Plex
Pro
human
27-plex
test
kit
LUMINEX
200
were
used
assay
cytokines/chemokines/growth
factors
fasting
plasma
samples.
Results
characterized
by
significant
general
immnosuppression,
reductions
T
helper
1
(Th)1
cell
growth
profiles,
immune-inflammatory
responses
system,
interleukin
(IL)1β,
IL6,
IL7,
IL12p70,
IL13,
GM-CSF,
MCP-1
as
compared
controls.
These
7
cytokines/chemokines
exhibit
neuroprotective
effects
at
physiologic
concentrations.
In
multivariate
analyses,
three
neurotoxic
chemokines,
CCL11,
CCL5,
CXCL8,
emerged
predictors
aMCI.
Logistic
regression
showed
that
best
predicted
combining
IL1β,
MCP-1,
years
education
(all
inversely
associated)
CCL5
(positively
associated).
We
38.2%
variance
qMCI
score
explained
(inversely
DSOA
not
associated
any
data.
Discussion
dysbalance
between
lowered
levels
cytokines
relative
increases
chemokines
are
key
Future
MCI
research
should
always
control
for
confounding
affective
symptoms.
This
retrospective
chart
review
study
aimed
to
investigate
the
differences
in
Rorschach
test
and
Minnesota
Multiphasic
Personality
Inventory
(MMPI)-II
profiles
among
patients
with
Kraepelinian
schizophrenia,
those
DSM-wise
controls.
schizophrenia
is
characterised
by
a
chronic,
deteriorative
disease
course
predominance
of
negative
symptoms.
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 2, 2024
Abstract
Objectives
The
pathophysiology
of
amnestic
Mild
Cognitive
Impairment
(aMCI)
is
largely
unknown,
although
some
papers
found
signs
immune
activation.
To
assess
the
cytokine
network
in
aMCI
after
excluding
patients
with
major
depression
(MDD)
and
to
examine
profiles
quantitative
(qMCI)
distress
symptoms
old
age
(DSOA)
scores.
Design:
A
case-control
study.
Setting:
Department
Psychiatry
a
University
Hospital,
Bangkok,
Thailand.
Participants
:
61
Thai
participants
60
healthy
adults
(both
without
MDD).
Measurements
Bio-Plex
Pro
human
27-plex
test
kit
was
used
assay
cytokines/chemokines/growth
factors
fasting
plasma
samples.
Results
characterized
by
significant
general
immunosuppression,
reductions
T
helper
1
(Th)1
cell
growth
profiles,
immune-inflammatory
responses
system,
interleukin
(IL)1β,
IL6,
IL7,
IL12p70,
IL13,
GM-CSF,
MCP-1.
These
7
cytokines/chemokines
exhibit
neuroprotective
effects
at
physiologic
concentrations.
In
multivariate
analyses,
three
neurotoxic
chemokines,
CCL11,
CCL5,
CXCL8,
emerged
as
predictors
aMCI.
Logistic
regression
showed
that
best
predicted
combining
IL1β,
MCP-1,
years
education
(all
inversely
associated)
CCL5
(positively
associated).
We
38.2%
variance
qMCI
score
explained
(inversely
DSOA
not
associated
any
data.
Discussion
dysbalance
between
lowered
levels
cytokines
relative
increases
chemokines
are
key
Future
MCI
research
should
always
control
for
confounding
affective
symptoms.
Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Март 14, 2023
Abstract
Background
The
binary
major
depressive
disorder
(MDD)
diagnosis
is
inadequate
and
should
never
be
used
in
research.
Aims
study's
objective
to
explicate
our
novel
precision
nomothetic
strategy
for
constructing
depression
models
based
on
adverse
childhood
experiences
(ACEs),
lifetime
current
phenome,
biomarker
(atherogenicity
indices)
scores.
Methods
This
study
assessed
recurrence
of
illness
(ROI:
namely
episodes
suicidal
behaviors),
behaviors
the
phenome
depression,
neuroticism,
dysthymia,
anxiety
disorders,
lipid
biomarkers
(including
ApoA,
ApoB,
free
cholesterol
cholesteryl
esters,
triglycerides,
high
density
lipoprotein
cholesterol)
67
normal
controls
66
MDD
patients.
We
computed
atherogenic
reverse
transport
indices.
Results
were
able
extract
one
factor
from
a)
comprising
ROI,
traits
such
as
dysthymia
b)
acute
phase
(based
quality
life
scores).
PLS
analysis
showed
that
55.7%
variance
+
was
explained
by
increased
atherogenicity,
neglect
sexual
abuse,
while
atherogenicity
partially
mediated
effects
neglect.
Cluster
generated
a
cluster
patients
with
dysmood
disorder,
which
externally
validated
characterized
scores
all
clinical
features.
Conclusions
outcome
not
represented
variable
(MDD
or
not),
but
rather
multiple
dimensional
biomarkers,
subclinical
traits,
including
behaviors.
Research Square (Research Square),
Год журнала:
2023,
Номер
unknown
Опубликована: Июнь 24, 2023
Abstract
Comprehensive
immunological
profiles
have
not
been
studied
in
relation
to
methamphetamine
(MA)
use,
MA
dependency,
or
MA-induced
psychosis
(MAP).
Using
the
BioPlex
Pro
Human
Cytokine
48-Plex
panel,
this
study
measured
M1
macrophage,
T
helper
(Th)-1,
Th-2,
growth
factor,
and
chemokine
profiles,
as
well
immune
inflammatory
response
system
(IRS)
compensatory
immunoregulatory
(CIRS)
peripheral
blood
samples
from
patients
with
use
(n=51),
dependence
(n=47),
MAP
(n=43)
comparison
healthy
controls
(n=43).
We
discovered
that
persistent
had
a
robust
dose-dependent
suppressive
impact
on
all
suggesting
extensive
immunosuppression.
The
most
reliable
biomarker
profile
of
is
combination
substantial
CIRS
suppression
rise
selected
pro-inflammatory
cytokines,
namely
CCL27
(CTACK),
CCL11
(eotaxin),
interleukin
(IL)-1α.
In
addition,
dependency
related
more
severe
immunosuppression,
demonstrated
by
lower
stem
cell
factor
higher
IL-10
levels.
significant
decrease
particularly
CIRS,
an
increase
CCL5
(RANTES),
IL-1α,
IL-12p70
signaling.
conclusion,
long-term
severely
undermine
homeostasis.
This
results
widespread
which
may
likelihood
infectious
illness
exacerbate
disorders
such
hepatitis
AIDS.
Elevated
levels
CCL5,
CCL11,
CCL27,
and/or
be
associated
(atherosclerosis,
cutaneous
inflammation,
aberrations,
hypospermatogenesis)
central
(neuroinflammation,
neurotoxic,
neurodegenerative,
depression,
anxiety
psychosis)
side
effects.